Author:
Peigné Sophie,Bouzom François,Brendel Karl,Gesson Charlotte,Fouliard Sylvain,Chenel Marylore
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. B Regulation (EC) no 1901/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use and amending Regulation (EEC) no 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004. 2012. http://eur-lex.europa.eu/LexUriServ/site/en/consleg/2006/R/02006R1901-20070126en.pdf . Accessed 5 Nov 2012
2. Delgizzi LJ, Ueda JN (1990) Using inotropic and vasodilating agents in paediatric patients with cardiac disease. AACN Clin Issues Crit Care Nurs 1:131–147
3. Veldman A, Rupp S, Schranz D (2006) New inotropic pharmacologic strategies targeting the failing myocardium in the newborn and infant. Mini Rev Med Chem 6:785–792
4. Rijnbeek PR, Witsenburg M, Schrama E, Hess J, Kors JA (2001) New normal limits for the paediatric electrocardiogram. Eur Heart J 22:702–711
5. Fleming S, Thompson M, Stevens R, Heneghan C, Plüddemann A, Maconochie I, Tarassenko L, Mant D (2011) Normal ranges of heart rate and respiratory rate in children from birth to 18 years of age: a systematic review of observational studies. Lancet 377(9770):1011–1018
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献